Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma
Clinical trial NCT03921879 · UNKNOWN
Trial details
- NCT number
- NCT03921879
- Sponsor
- Oncotartis, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-29
- Primary completion
- 2021-04-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.